Want to see AU:BGT full AI Analyst Report?
Bio-Gene Technology Ltd. (BGT) Financial Statements
Bio-Gene Technology Ltd. Financial Overview
Bio-Gene Technology Ltd.'s market cap is currently $6.13M. The company's EPS TTM is $-0.01; its P/E ratio is -1.87; Bio-Gene Technology Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 18.32K | $ 149.23K | $ 445.73K |
| Gross Profit | $ -42.00K | $ -245.78K | $ -301.45K | $ -164.04K | $ 178.59K |
| Operating Income | $ -3.41M | $ -3.07M | $ -3.06M | $ -3.63M | $ -3.41M |
| EBITDA | $ -3.36M | $ -2.58M | $ -2.97M | $ -3.14M | $ -2.92M |
| Net Income | $ -2.33M | $ -2.58M | $ -2.41M | $ -3.10M | $ -2.91M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.94M | $ 1.14M | $ 2.21M | $ 2.99M | $ 6.34M |
| Total Assets | $ 2.61M | $ 2.15M | $ 3.16M | $ 3.84M | $ 7.30M |
| Total Debt | $ 0.00 | $ 51.21K | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -1.94M | $ -1.14M | $ -2.21M | $ -2.99M | $ -6.34M |
| Total Liabilities | $ 519.76K | $ 522.98K | $ 368.45K | $ 613.88K | $ 1.03M |
| Stockholders' Equity | $ 2.09M | $ 1.63M | $ 2.79M | $ 3.22M | $ 6.27M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ -2.54M | $ -2.76M | $ -3.28M | $ 36.67K |
| Operating Cash Flow | $ -1.94M | $ -2.54M | $ -2.75M | $ -3.28M | $ 43.52K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -5.70K | $ 0.00 | $ -6.84K |
| Financing Cash Flow | $ 2.74M | $ 1.47M | $ 1.98M | $ -75.00K | $ 4.41M |
Currency in AUD